In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia. / Hogan, M J; Gjedde, A; Hakim, A M.

In: Journal of Neurochemistry, Vol. 58, No. 1, 1992, p. 186-91.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hogan, MJ, Gjedde, A & Hakim, AM 1992, 'In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia.', Journal of Neurochemistry, vol. 58, no. 1, pp. 186-91.

APA

Hogan, M. J., Gjedde, A., & Hakim, A. M. (1992). In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia. Journal of Neurochemistry, 58(1), 186-91.

Vancouver

Hogan MJ, Gjedde A, Hakim AM. In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia. Journal of Neurochemistry. 1992;58(1):186-91.

Author

Hogan, M J ; Gjedde, A ; Hakim, A M. / In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia. In: Journal of Neurochemistry. 1992 ; Vol. 58, No. 1. pp. 186-91.

Bibtex

@article{008f73e0b31511debc73000ea68e967b,
title = "In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia.",
abstract = "The blood-brain barrier permeability of the competitive N-methyl-D-aspartate receptor antagonist CGS-19755 [cis-4-(phosphonomethyl)-2-piperidine carboxylic acid] was assessed in normal and ischemic rat brain. The brain uptake index of CGS-19755 relative to iodoantipyrine was assessed using the Oldendorf technique in normal brain. The average brain uptake index in brain regions supplied by the middle cerebral artery was 0.15 +/- 0.35% (mean +/- SEM). The unidirectional clearance of CGS-19755 from plasma across the blood-brain barrier was determined from measurements of the volume of distribution of CGS-19755 in brain. These studies were performed in normal rats and in rats with focal cerebral ischemia produced by combined occlusion of the proximal middle cerebral artery and ipsilateral common carotid artery. In normal rats the regional plasma clearance across the blood-brain barrier was low, averaging 0.015 ml 100 g-1 min-1. In ischemic rats this clearance value averaged 0.019 ml 100 g-1 min-1 in the ischemic hemisphere and 0.009 ml 100 g-1 min-1 in the nonischemic hemisphere. No significant regional differences in plasma clearance of CGS-19755 were observed in either normal or ischemic rats except in cortex injured by electrocautery where a 14-fold increase in clearance across the blood-brain barrier was measured. We conclude that CGS-19755 crosses the blood-brain barrier very slowly, even in acutely ischemic tissue.",
author = "Hogan, {M J} and A Gjedde and Hakim, {A M}",
year = "1992",
language = "English",
volume = "58",
pages = "186--91",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia.

AU - Hogan, M J

AU - Gjedde, A

AU - Hakim, A M

PY - 1992

Y1 - 1992

N2 - The blood-brain barrier permeability of the competitive N-methyl-D-aspartate receptor antagonist CGS-19755 [cis-4-(phosphonomethyl)-2-piperidine carboxylic acid] was assessed in normal and ischemic rat brain. The brain uptake index of CGS-19755 relative to iodoantipyrine was assessed using the Oldendorf technique in normal brain. The average brain uptake index in brain regions supplied by the middle cerebral artery was 0.15 +/- 0.35% (mean +/- SEM). The unidirectional clearance of CGS-19755 from plasma across the blood-brain barrier was determined from measurements of the volume of distribution of CGS-19755 in brain. These studies were performed in normal rats and in rats with focal cerebral ischemia produced by combined occlusion of the proximal middle cerebral artery and ipsilateral common carotid artery. In normal rats the regional plasma clearance across the blood-brain barrier was low, averaging 0.015 ml 100 g-1 min-1. In ischemic rats this clearance value averaged 0.019 ml 100 g-1 min-1 in the ischemic hemisphere and 0.009 ml 100 g-1 min-1 in the nonischemic hemisphere. No significant regional differences in plasma clearance of CGS-19755 were observed in either normal or ischemic rats except in cortex injured by electrocautery where a 14-fold increase in clearance across the blood-brain barrier was measured. We conclude that CGS-19755 crosses the blood-brain barrier very slowly, even in acutely ischemic tissue.

AB - The blood-brain barrier permeability of the competitive N-methyl-D-aspartate receptor antagonist CGS-19755 [cis-4-(phosphonomethyl)-2-piperidine carboxylic acid] was assessed in normal and ischemic rat brain. The brain uptake index of CGS-19755 relative to iodoantipyrine was assessed using the Oldendorf technique in normal brain. The average brain uptake index in brain regions supplied by the middle cerebral artery was 0.15 +/- 0.35% (mean +/- SEM). The unidirectional clearance of CGS-19755 from plasma across the blood-brain barrier was determined from measurements of the volume of distribution of CGS-19755 in brain. These studies were performed in normal rats and in rats with focal cerebral ischemia produced by combined occlusion of the proximal middle cerebral artery and ipsilateral common carotid artery. In normal rats the regional plasma clearance across the blood-brain barrier was low, averaging 0.015 ml 100 g-1 min-1. In ischemic rats this clearance value averaged 0.019 ml 100 g-1 min-1 in the ischemic hemisphere and 0.009 ml 100 g-1 min-1 in the nonischemic hemisphere. No significant regional differences in plasma clearance of CGS-19755 were observed in either normal or ischemic rats except in cortex injured by electrocautery where a 14-fold increase in clearance across the blood-brain barrier was measured. We conclude that CGS-19755 crosses the blood-brain barrier very slowly, even in acutely ischemic tissue.

M3 - Journal article

C2 - 1727429

VL - 58

SP - 186

EP - 191

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 1

ER -

ID: 14943170